Aptose Biosciences (APTO) Commences Public Offering of Common Shares

Go back to Aptose Biosciences (APTO) Commences Public Offering of Common Shares

Aptose Announces Proposed Public Offering of Common Shares

December 16, 2019 4:18 PM UTC

SAN DIEGO and TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose or the Company) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public offering of its common shares (the Offering). In addition, Aptose intends to grant the Underwriters a 30-day option to purchase up to an additional 15% of the common shares offered in the Offering. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or... More